ROE
Astoria US Quality Kings ETF
ROE is an actively managed ETF that provides long-term capital appreciation by investing in US high-quality stocks in the large- and mid-cap space based on proprietary quantitative screens. Holdings are equally weighted, and sector optimized.
US
EQUITY
Active
MANAGEMENT STYLE
$ 242.2 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Aug 01, 2023 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PTC INC. | 1.4 % |
| HASBRO INC | 1.3 % |
| GEN DIGITAL INC | 1.3 % |
| LOCKHEED MARTIN CORP | 1.3 % |
| ELI LILLY & CO | 1.2 % |
| PAYCOM SOFTWARE INC | 1.2 % |
| MCKESSON CORP | 1.2 % |
| UNITED RENTALS INC | 1.2 % |
| EOG RESOURCES, INC. | 1.2 % |
| HALOZYME THERAPEUTICS INC | 1.1 % |
Constituent Breakdown
| Number of holdings | 100 |
| Herfindahl-Hirschman Index | 100 |
| Wgt avg mkt cap (mns) | $397,590 |
| Large cap (>$10bn) | 94.2% |
| Mid cap ($2-10bn) | 3.9% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 93.5 % |
 |
IRELAND | 1.7 % |
 |
NETHERLANDS | 1.1 % |
 |
PUERTO RICO | 1.0 % |
 |
LUXEMBOURG | 0.9 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 20.7% | 23.1% | 17.6% | 22.1% | -- | -- | -- | 18.2% |
| Dividend Yield | 0.6% | 0.9% | 1.1% | 1.3% | -- | -- | -- | 1.3% |
| Total Returns | 21.3% | 24.1% | 18.6% | 23.4% | -- | -- | -- | 19.5% | Ann. Volatility | 15.2% | 15.2% | 17.0% | 15.8% | -- | -- | -- | 15.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.03 | 78% |
| MSCI EAFE | 0.72 | 57% |
| MSCI Emg Mkts | 0.47 | 62% |
Liquidity Measures
| Avg. volume (000) | 72 |
| ADV traded (mns) | $3 |
| Turnover | 1.2% |
| Avg. Bid/Ask (% of price) | 0.06% |
Technical Indicators
| 30d moving avg. (EMA) | $43.07 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.08/-0.02 |
| Bollinger Bands (Upper/Lower) | $43.88/$42.39 |
| Short interest (% of AUM) | 0.6% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ROE |
Expenses vs. ROE |
ALTAR Score™ vs. ROE |
|---|---|---|---|---|
| EQWL | Invesco S&P 100 Equal Weight ETF | 38.6% | -19 bp | -0.9% |
| GQQQ | Astoria US Quality Growth Kings ETF | 38.5% | -14 bp | -1.2% |
| ROUS | Hartford Multifactor US Equity ETF | 36.0% | -30 bp | +0.2% |
| QUS | State Street SPDR MSCI USA StrategicFactors ETF | 34.1% | -34 bp | -1.3% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 33.3% | -34 bp | -1.2% |
| DSPY | Tema S&P 500 Historical Weight ETF | 33.0% | -31 bp | -1.5% |
| FLRG | Fidelity U.S. Multifactor ETF | 32.6% | -34 bp | +0.5% |
| JQTY | Jensen U.S. Quality Index ETF | 31.9% | -24 bp | -0.7% |
| OEI | Optimized Equity Income ETF | 31.8% | +53 bp | -2.8% |
| TOPC | iShares S&P 500 3% Capped ETF | 31.7% | -34 bp | -1.5% |
Risk and Returns: ROE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.0%
ALTAR SCORE™
75th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. ROE's ALTAR Score™ is approximately 0.7 standard
deviations above the category average. This places ROE in the 75th percentile
among funds in the category.
Sell-Side Consensus
$51.92
PRICE TARGET
+26.7%
UPSIDE